Navigation path

Pharmaceuticals - Community Register

  

List of referrals for human medicinal products

Vascace Plus and associated names

Product name: Vascace Plus and associated names
Also marketed in the EU under the name(s): Co-Inhibace, Dynorm Plus, Inhibace plus, Inibace Plus
INN: cilazapril and hydrochlorothiazide
Indication: Treatment of hypertension in patients not responding satisfactorily to each component administered alone.
Marketing Authorisation Holder: Not applicable

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/01/2011 Referral EMEA/H/A-30/1153 (2011)388 of 21/01/2011